Tilray Brands, Inc. (TLRY)

Market Cap	1.68B
Revenue (ttm)	627.12M
Net Income (ttm)	-1.45B
Shares Out	703.26M
EPS (ttm)	-2.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,597,650
Open	2.39
Previous Close	2.35
Day's Range	2.33 - 2.42
52-Week Range	1.50 - 5.12
Beta	2.52
Analysts	Hold
Price Target	3.48 (+45.61%)
Earnings Date	Oct 4, 2023

About TLRY

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-ba...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 1,600
• Stock Exchange: NASDAQ
• Ticker Symbol: TLRY

Financial Performance

In 2023, Tilray's revenue was $627.12 million, a decrease of -0.20% compared to the previous year's $628.37 million. Losses were -$1.45 billion, 204.7% more than in 2022.

Analyst Forecast

According to 6 analysts, the average rating for TLRY stock is "Hold." The 12-month stock price forecast is $3.48, which is an increase of 45.61% from the latest price.

Price Target

$3.48

(45.61% upside)

Analyst Consensus: Hold